Regenerx Financial Statements From 2010 to 2024
| RGRXDelisted Stock | USD 0.0009 0.0001 12.50% |
Check Regenerx Biopharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenerx main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Regenerx financial statements analysis is a perfect complement when working with Regenerx Biopharm Valuation or Volatility modules.
Regenerx |
Regenerx Biopharm In OTC Stock Return On Asset Analysis
Regenerx Biopharm's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Regenerx Biopharm Return On Asset | -0.84 |
Most of Regenerx Biopharm's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regenerx Biopharm In is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Regenerx Biopharm In has a Return On Asset of -0.8397. This is 90.4% lower than that of the Biotechnology sector and 96.44% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Regenerx Biopharm Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Regenerx Biopharm's current stock value. Our valuation model uses many indicators to compare Regenerx Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regenerx Biopharm competition to find correlations between indicators driving Regenerx Biopharm's intrinsic value. More Info.Regenerx Biopharm In is rated second in return on asset category among related companies. It is currently regarded as top stock in operating margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Regenerx Biopharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regenerx Biopharm's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Regenerx Biopharm's earnings, one of the primary drivers of an investment's value.About Regenerx Biopharm Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Regenerx Biopharm income statement, its balance sheet, and the statement of cash flows. Regenerx Biopharm investors use historical funamental indicators, such as Regenerx Biopharm's revenue or net income, to determine how well the company is positioned to perform in the future. Although Regenerx Biopharm investors may use each financial statement separately, they are all related. The changes in Regenerx Biopharm's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Regenerx Biopharm's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Regenerx Biopharm Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Regenerx Biopharm. Please read more on our technical analysis and fundamental analysis pages.
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |